Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 CAD | +2.78% | +5.71% | +27.59% |
04-22 | XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal | MT |
04-22 | XORTX Announces Publication of Key Research in ADPKD | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.59% | 7.64M | |
+9.33% | 106B | |
+0.86% | 104B | |
+6.78% | 23.25B | |
-13.33% | 22.5B | |
-6.64% | 18.7B | |
-37.08% | 17.95B | |
-11.04% | 16.99B | |
+7.56% | 14.26B | |
+40.06% | 12.76B |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Therapeutics Appoints Former Pfizer Executive Stacy Evans as Chief Business Officer